|
Market Closed -
OTC Markets
11:54:04 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| Market Cap | 23.05M 20.69M 19.1M 17.32M 32.37M 2.19B 32.77M 229M 90.95M 1.15B 86.52M 84.67M 3.64B | P/E 2020 |
-0.97x | P/E 2021 | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 20.76M 18.63M 17.21M 15.6M 29.16M 1.97B 29.52M 206M 81.92M 1.03B 77.93M 76.26M 3.28B | EV / Sales 2020 |
59,104,361x | EV / Sales 2021 | 103,098,403x |
| Free-Float |
100% | Yield 2020 * |
-
| Yield 2021 | - |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.27 |
| 5 years | 0 | | 0.27 |
| 10 years | 0 | | 2.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Terry Booth
CEO | Chief Executive Officer | 62 | 2020-12-31 |
Roger Sykes
COO | Chief Operating Officer | - | 2022-08-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Hanoz Kapadia
CHM | Chairman | - | 2021-05-25 |
John Esteireiro
BRD | Director/Board Member | 56 | 2020-11-16 |
Jillian Swainson
BRD | Director/Board Member | - | 2022-07-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/6/23 | Other | Chief Operating Officer | 0 | 0% | ||
| 10/14/22 | Option | Chief Technology Officer | 1,400,000 | 0.4775% | ||
| 10/14/22 | Option | Chief Executive Officer | 1,000,000 | 0.3411% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 254 | |
| +0.22% | -0.14% | +55.12% | +128.82% | 1,140B | |
| +0.91% | +3.61% | +41.21% | +84.57% | 641B | |
| -0.12% | -0.93% | +25.59% | +106.14% | 507B | |
| +0.63% | +2.33% | +49.21% | +67.82% | 383B | |
| +0.86% | -4.37% | +61.16% | +37.93% | 347B | |
| +1.02% | +1.80% | +24.84% | +53.75% | 293B | |
| -0.25% | +1.62% | +2.20% | +26.65% | 266B | |
| +0.75% | +2.05% | +53.85% | +71.25% | 240B | |
| +0.25% | +1.64% | +32.05% | +107.62% | 197B | |
| Average | +0.43% | +2.63% | +38.36% | +76.06% | 401.38B | |
| Weighted average by Cap. | +0.44% | +2.98% | +42.20% | +88.48% |
| 2020 | 2021 | |
|---|---|---|
| Net sales | 0.22 0.2 0.18 0.17 0.31 21.04 0.31 2.2 0.87 11.03 0.83 0.81 34.97 | 0.72 0.64 0.59 0.54 1.01 68.12 1.02 7.13 2.83 35.71 2.69 2.63 113.23 |
| Net income | -23.34M -20.95M -19.34M -17.54M -32.78M -2.22B -33.19M -232M -92.11M -1.16B -87.62M -85.75M -3.69B | -25.26M -22.67M -20.93M -18.98M -35.48M -2.4B -35.92M -251M -99.68M -1.26B -94.82M -92.79M -3.99B |
| Net Debt | -10.7M -9.6M -8.87M -8.04M -15.03M -1.02B -15.22M -106M -42.23M -533M -40.17M -39.31M -1.69B | -2.29M -2.05M -1.9M -1.72M -3.21M -217M -3.25M -22.73M -9.03M -114M -8.59M -8.4M -361M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- AUSAF Stock
Select your edition
All financial news and data tailored to specific country editions
